Efficacy and safety profile of avelumab monotherapy
- 28 August 2021
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 166, 103464
- https://doi.org/10.1016/j.critrevonc.2021.103464
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31571417)
- Natural Science Foundation of Zhejiang Province (LZ21H160006)
This publication has 61 references indexed in Scilit:
- Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma PatientsClinical Cancer Research, 2016
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trialThe Lancet, 2016
- Safety and efficacy of nivolumab in the treatment of cancers: A meta‐analysis of 27 prospective clinical trialsInternational Journal of Cancer, 2016
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialThe Lancet Oncology, 2016
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialThe Lancet, 2016
- Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral CenterCancer Immunology Research, 2015
- Cytotoxic T-Lymphocyte-Associated Antigen 4 Antibody-Induced Colitis and Its Management with InfliximabDigestive Diseases and Sciences, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997
- Operating Characteristics of a Rank Correlation Test for Publication BiasBiometrics, 1994